Atypical presentations of inclusion body myositis: Clinical characteristics and <scp>long‐term</scp> outcomes

Abstract

A significant proportion of IBM patients may have an atypical presentation. Recognition of such heterogeneity could improve early diagnosis, prevent unnecessary immunotherapy, and provide insight for future diagnostic criteria development and clinical trials.